Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)
National Institutes of Health
Posted Oct 9, 2026
Description
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications to characterize genomic variation to assess the impact of individual variants on genome function. This will be accomplished by systematically perturbing variants or elements using one or more high-throughput methods; collecting data on the effects of variants in DNA, RNA, or protein-coding elements on molecular, cellular, or organismal phenotypes; and developing robust, reproducible, and portable data processing pipelines. Centers funded through this initiative will become a part of the Impact of Genomic Variation on Function (IGVF) Consortium. As consortium members, centers will work together to ensure all consortium resources are accessible to a wide variety of potential users. Centers are also expected to collaborate with other consortium components to coordinate assays, variants, and cell types, and to develop shared analysis strategies to meet consortium goals.
AI Summary
This funding opportunity supports projects that aim to analyze genomic variations and their effects on genome function and phenotypes through high-throughput methods. Eligible applicants are research centers that will join the Impact of Genomic Variation on Function (IGVF) Consortium and collaborate with other members to share resources and strategies.
Funding Details
- Maximum Award
- $2,000,000
Key Dates
Quick Facts
- CFDA Number
- 93.172
- Funder Type
- Federal Agency
- Grant Level
- FEDERAL
- Last Verified
- Oct 9, 2026
Categories
Geographic Scope
national
GL-78EA5778ea5767-7886-49be-85ac-13b006d74bc2
Intelligence
Ready to apply?
Visit the funder's website to start your application.